Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
Abstract Virtually all patients with multiple myeloma become unresponsive to treatment over time. Relapsed/refractory multiple myeloma (RRMM) is accompanied by the clonal evolution of myeloma cells with heterogeneous genomic aberrations and profound changes of the bone marrow microenvironment (BME)....
Guardado en:
Autores principales: | Stephan M. Tirier, Jan-Philipp Mallm, Simon Steiger, Alexandra M. Poos, Mohamed H. S. Awwad, Nicola Giesen, Nicola Casiraghi, Hana Susak, Katharina Bauer, Anja Baumann, Lukas John, Anja Seckinger, Dirk Hose, Carsten Müller-Tidow, Hartmut Goldschmidt, Oliver Stegle, Michael Hundemer, Niels Weinhold, Marc S. Raab, Karsten Rippe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa70b923d8a843a39ddf7f12f81781e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The glycome of normal and malignant plasma cells.
por: Thomas M Moehler, et al.
Publicado: (2013) -
Combating subclonal evolution of resistant cancer phenotypes
por: Samuel W. Brady, et al.
Publicado: (2017) -
Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myeloma.
por: Alboukadel Kassambara, et al.
Publicado: (2012) -
Quantifying the influence of mutation detection on tumour subclonal reconstruction
por: Lydia Y. Liu, et al.
Publicado: (2020) -
Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression
por: Danielle C. Croucher, et al.
Publicado: (2021)